Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular Degeneration
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare 12-month results of two single initial
treatments-photodynamic therapy with verteporfin alone and this therapy combined with
intravitreal bevacizumab-for neovascular age-related macular degeneration, not including
patients with polypoidal choroidal vasculopathy who were presumed to have age-related macular
degeneration.